Idiopathic pulmonary fibrosis: Systematic review and meta-analysis of treatment options and outcomes, 1970 to present

被引：0
|
作者：
Schoelles, K [1 ]
Estok, RP [1 ]
Stone, LR [1 ]
Cella, CA [1 ]
Kaye, R [1 ]
Nathan, S [1 ]
机构：
[1] MetaWorks Inc, Medford, MA USA
来源：
CHEST | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1378/chest.124.4_MeetingAbstracts.193S-b
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：193S / 193S
页数：1
相关论文
共 50 条
  • [21] The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Chen, Ching-Yi
    Chen, Chao-Hsien
    Wang, Cheng-Yi
    Lai, Chih-Cheng
    Chao, Chien-Ming
    Wei, Yu-Feng
    [J]. RESPIRATORY RESEARCH, 2021, 22 (01)
  • [22] Impact of emphysema on mortality in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Wang, Yanhong
    Zou, Ruyi
    Yao, Yu
    Tang, Cheng
    Luo, Jing
    Lin, Minjie
    [J]. EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [23] Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis
    Pitre, Tyler
    Mah, Jasmine
    Helmeczi, Wryan
    Khalid, Muhammad Faran
    Cui, Sonya
    Zhang, Melanie
    Husnudinov, Renata
    Su, Johnny
    Banfield, Laura
    Guy, Brent
    Coyne, Jade
    Scallan, Ciaran
    Kolb, Martin R. J.
    Jones, Aaron
    Zeraatkar, Dena
    [J]. THORAX, 2022, 77 (12) : 1243 - 1250
  • [24] Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Kamiya, Hiroyuki
    Panlaqui, Ogee
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [25] The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Wang, Yan
    Ji, Zile
    Xu, Baichuan
    Li, Suyun
    Xie, Yang
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis
    Kamiya, Hiroyuki
    Panlaqui, Ogee Mer
    [J]. BMJ OPEN, 2019, 9 (05):
  • [27] The efficacy and safety of pirfenidone in the treatment of HPS-related pulmonary fibrosis and Idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Ma, Y. -J.
    Zhang, Q.
    Wang, C. -X.
    Wu, W.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (22) : 8411 - 8424
  • [28] Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
    Laura L. Meijer
    Anna J. Alberga
    Jacob K. de Bakker
    Hans J. van der Vliet
    Tessa Y. S. Le Large
    Nicole C. T. van Grieken
    Ralph de Vries
    Freek Daams
    Barbara M. Zonderhuis
    Geert Kazemier
    [J]. Annals of Surgical Oncology, 2018, 25 : 2681 - 2692
  • [29] Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis
    Meijer, Laura L.
    Alberga, Anna J.
    de Bakker, Jacob K.
    van der Vliet, Hans J.
    Le Large, Tessa Y. S.
    van Grieken, Nicole C. T.
    de Vries, Ralph
    Daams, Freek
    Zonderhuis, Barbara M.
    Kazemier, Geert
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (09) : 2681 - 2692
  • [30] Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Rogliani, Paola
    Calzetta, Luigino
    Cavalli, Francesco
    Matera, Maria Gabriella
    Cazzola, Mario
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 40 : 95 - 103
12345